Evolution of the Average Target: Experian plc

Evolution of the Target Price: Experian plc

Changes in Analyst Recommendations: Experian plc

e7087614bb98c6d7c24ff.1FdLazT3YCcVrSjEF5oenQ10pHT_fxcMB_zbcNVQjrE.vzQKPwSZWEB83379IOxw8UBC0i7HKyQ5X5mKOoUyxsiQCAMoAr8YSGXHSw~c7c3c06613ed718368306ae63675d34f
07-16 Experian: Underlying growth remains resilient, H2 recovery in sight Alphavalue
07-13 Morgan Stanley Research: Experian to Log 7% Organic Revenue Growth in Fiscal Q1 MT
06-10 Deutsche Bank Cuts Experian PT, Affirms Buy Rating MT
06-10 Deutsche Bank Research raises easyJet to 'hold' AN
05-26 Stifel Reduces Experian's PT, Affirms Buy Rating MT
05-26 Stifel Lowers Target on Experian, Shares Stagnate Zonebourse
05-26 Barclays ups British Land; BofA cuts Vodafone AN
05-22 UBS Maintains Buy Rating and Raises Price Target for Experian Zonebourse
05-21 Deutsche, Goldman cut Experian price targets AN
05-21 Experian Kept at Buy as BofA Notes In-line FY26 Results, AI Concerns; Estimates Updated MT
05-19 AlphaValue/Baader Europe Upgrades Experian to Add, Lifts PT MT
04-22 AlphaValue/Baader Europe Downgrades Experian to Reduce, Trims PT MT
04-02 RBC raises Berkeley; Berenberg raises BHP AN
02-09 Deutsche cuts Unilever; Jefferies cuts Greggs AN
02-09 AlphaValue/Baader Europe Downgrades Experian on AI-driven Price, Competitive Pressures MT
02-06 Experian: Valuation reset amid AI uncertainity Alphavalue
01-22 BofA Trims Experian EPS Forecasts on Expected 'Marginally Lower' FY26 Organic Revenue Growth; Buy Rating Kept MT
01-21 Experian reaffirms FY guidance after steady Q3 Alphavalue
12-11 Experian on JPMorgan focus list at 'overweight' AN
12-08 JPMorgan cuts M&G, UBS cuts Trainline AN
11-21 Citi Upgrades Experian to Buy, Trims PT MT
11-21 Citi lifts Experian; Goldman Sachs cuts Ithaca AN
11-12 Tandem Diabetes Care, Inc. Appoints Sandra Beaver to Board of Directors, Effective November 7, 2025 CI
11-12 Experian benefits from AI-led growth and resilient margins Alphavalue
11-10 AlphaValue/Baader Europe Upgrades Experian to Add Rating, Boosts PT MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+37.61%
+30.06%
+26.13%
-7.01%
Average +21.70%
Weighted average by Cap. +35.64%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
36.58USD
Average target price
50.34USD
Spread / Average Target
+37.61%
High Price Target
63.20USD
Spread / Highest target
+72.77%
Low Price Target
31.70USD
Spread / Lowest Target
-13.35%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

alphavalue Savitri Kakkar
Deutsche Bank Securities
Stifel Nicolaus
AlphaValue/Baader Europe
Citigroup
Bernstein
RBC Capital Markets
Jefferies & Co.
UBS
Morgan Stanley
Barclays
Goldman Sachs
JPMorgan
Credit Suisse
Bank of America Securities/Merrill Lynch
Exane BNP
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
36.58USD
Average target price
50.34USD
Spread / Average Target
+37.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. EXPN Stock
  4. Consensus Experian plc